Literature DB >> 19706290

Neuroblastoma GOTO cells are hypersensitive to disruption of lipid rafts.

Ryosaku Tomioka1, Natsumi Minami, Ai Kushida, Shiho Horibe, Ippei Izumi, Akira Kato, Keiko Fukushima, Hiroko Ideo, Katsuko Yamashita, Shigehisa Hirose, Yuji Saito.   

Abstract

GOTO cells, a neuroblastoma cell line retaining the ability to differentiate into neuronal or Schwann cells, were found to be rich in membrane rafts containing ganglioside GM2 and hypersensitive to lipid raft-disrupting methyl-beta-cyclodextrin (MbetaCD); the GM2-rich rafts and sensitivity to MbetaCD were markedly diminished upon their differentiation into Schwann cells. We first raised a monoclonal antibody that specifically binds to GOTO cells but not to differentiated Schwann cells and determined its target antigen as ganglioside GM2, which was shown to be highly concentrated in lipid rafts by its colocalization with flotillin, a marker protein of rafts. Disturbance of normal structure of the lipid raft by depleting its major constituent, cholesterol, with MbetaCD resulted in acute apoptotic cell death of GOTO cells, but little effects were seen on differentiated Schwann cells. Until this study, GM2-rich rafts are poorly characterized and MbetaCD hypersensitivity, which may have clinical implications, has not been reported.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706290     DOI: 10.1016/j.bbrc.2009.08.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Pathobiology of Christianson syndrome: Linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments.

Authors:  Mallory Kerner-Rossi; Maria Gulinello; Steven Walkley; Kostantin Dobrenis
Journal:  Neurobiol Learn Mem       Date:  2018-05-14       Impact factor: 2.877

2.  C282Y-HFE gene variant affects cholesterol metabolism in human neuroblastoma cells.

Authors:  Fatima Ali-Rahmani; Michael A Huang; C-L Schengrund; James R Connor; Sang Y Lee
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.